celiprolol has been researched along with Sleep Apnea Syndromes in 1 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Sleep Apnea Syndromes: Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Planès, C | 1 |
Foucher, A | 1 |
Leroy, M | 1 |
Dartois, N | 1 |
Juste, K | 1 |
Baillart, O | 1 |
Raffestin, B | 1 |
1 trial available for celiprolol and Sleep Apnea Syndromes
Article | Year |
---|---|
Effect of celiprolol treatment in hypertensive patients with sleep apnea.
Topics: Aged; Antihypertensive Agents; Celiprolol; Female; Heart Rate; Humans; Hypertension; Male; Middle Ag | 1999 |